
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
IL-6: Relevance for immunopathology of SARS-CoV-2
Ekaterina O. Gubernatorova, Е. А. Горшкова, Almina I. Polinova, et al.
Cytokine & Growth Factor Reviews (2020) Vol. 53, pp. 13-24
Open Access | Times Cited: 316
Ekaterina O. Gubernatorova, Е. А. Горшкова, Almina I. Polinova, et al.
Cytokine & Growth Factor Reviews (2020) Vol. 53, pp. 13-24
Open Access | Times Cited: 316
Showing 1-25 of 316 citing articles:
Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID‐19
Yong Gao, Tuantuan Li, Mingfeng Han, et al.
Journal of Medical Virology (2020) Vol. 92, Iss. 7, pp. 791-796
Open Access | Times Cited: 1052
Yong Gao, Tuantuan Li, Mingfeng Han, et al.
Journal of Medical Virology (2020) Vol. 92, Iss. 7, pp. 791-796
Open Access | Times Cited: 1052
The Science Underlying COVID-19
Peter P. Liu, Alice Blet, David Smyth, et al.
Circulation (2020) Vol. 142, Iss. 1, pp. 68-78
Closed Access | Times Cited: 789
Peter P. Liu, Alice Blet, David Smyth, et al.
Circulation (2020) Vol. 142, Iss. 1, pp. 68-78
Closed Access | Times Cited: 789
Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms
Amy D. Proal, Michael B. VanElzakker
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 743
Amy D. Proal, Michael B. VanElzakker
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 743
Cytokine storm and COVID-19: a chronicle of pro-inflammatory cytokines
Antonella F. Fara, Zan Mitrev, Rodney Alexander Rosalia, et al.
Open Biology (2020) Vol. 10, Iss. 9
Open Access | Times Cited: 329
Antonella F. Fara, Zan Mitrev, Rodney Alexander Rosalia, et al.
Open Biology (2020) Vol. 10, Iss. 9
Open Access | Times Cited: 329
Propolis and its potential against SARS-CoV-2 infection mechanisms and COVID-19 disease
Andresa Aparecida Berretta, Marcelo Augusto Duarte Silveira, José Manuel Cóndor Capcha, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 131, pp. 110622-110622
Open Access | Times Cited: 243
Andresa Aparecida Berretta, Marcelo Augusto Duarte Silveira, José Manuel Cóndor Capcha, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 131, pp. 110622-110622
Open Access | Times Cited: 243
The role of host genetics in the immune response to SARS‐CoV‐2 and COVID‐19 susceptibility and severity
Inna G. Ovsyannikova, Iana H. Haralambieva, Stephen N. Crooke, et al.
Immunological Reviews (2020) Vol. 296, Iss. 1, pp. 205-219
Open Access | Times Cited: 240
Inna G. Ovsyannikova, Iana H. Haralambieva, Stephen N. Crooke, et al.
Immunological Reviews (2020) Vol. 296, Iss. 1, pp. 205-219
Open Access | Times Cited: 240
Drug repurposing screens reveal cell-type-specific entry pathways and FDA-approved drugs active against SARS-Cov-2
Mark Dittmar, Jae Seung Lee, Kanupriya Whig, et al.
Cell Reports (2021) Vol. 35, Iss. 1, pp. 108959-108959
Open Access | Times Cited: 225
Mark Dittmar, Jae Seung Lee, Kanupriya Whig, et al.
Cell Reports (2021) Vol. 35, Iss. 1, pp. 108959-108959
Open Access | Times Cited: 225
No evidence for basigin/CD147 as a direct SARS-CoV-2 spike binding receptor
Jarrod Shilts, Thomas W.M. Crozier, Edward JD Greenwood, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 183
Jarrod Shilts, Thomas W.M. Crozier, Edward JD Greenwood, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 183
Monocytes and Macrophages, Targets of Severe Acute Respiratory Syndrome Coronavirus 2: The Clue for Coronavirus Disease 2019 Immunoparalysis
Asma Boumaza, Laëtitia Gay, Soraya Mezouar, et al.
The Journal of Infectious Diseases (2021) Vol. 224, Iss. 3, pp. 395-406
Open Access | Times Cited: 163
Asma Boumaza, Laëtitia Gay, Soraya Mezouar, et al.
The Journal of Infectious Diseases (2021) Vol. 224, Iss. 3, pp. 395-406
Open Access | Times Cited: 163
Azvudine is a thymus-homing anti-SARS-CoV-2 drug effective in treating COVID-19 patients
Jinlan Zhang, Yuhuan Li, Lulu Wang, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 159
Jinlan Zhang, Yuhuan Li, Lulu Wang, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 159
Interleukin-8 as a Biomarker for Disease Prognosis of Coronavirus Disease-2019 Patients
Lili Li, Jie Li, Meiling Gao, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 138
Lili Li, Jie Li, Meiling Gao, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 138
On inflammatory hypothesis of depression: what is the role of IL-6 in the middle of the chaos?
Elnaz Roohi, Nématollah Jaafari, Farshad Hashemian
Journal of Neuroinflammation (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 138
Elnaz Roohi, Nématollah Jaafari, Farshad Hashemian
Journal of Neuroinflammation (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 138
StackIL6: a stacking ensemble model for improving the prediction of IL-6 inducing peptides
Phasit Charoenkwan, Wararat Chiangjong, Chanin Nantasenamat, et al.
Briefings in Bioinformatics (2021) Vol. 22, Iss. 6
Closed Access | Times Cited: 109
Phasit Charoenkwan, Wararat Chiangjong, Chanin Nantasenamat, et al.
Briefings in Bioinformatics (2021) Vol. 22, Iss. 6
Closed Access | Times Cited: 109
The Role of Cytokines and Chemokines in Severe Acute Respiratory Syndrome Coronavirus 2 Infections
Ren‐Jun Hsu, Wei-Chieh Yu, Guan-Ru Peng, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 104
Ren‐Jun Hsu, Wei-Chieh Yu, Guan-Ru Peng, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 104
Lymphopenia an important immunological abnormality in patients with COVID‐19: Possible mechanisms
Abdollah Jafarzadeh, Sara Jafarzadeh, Parvin Nozari, et al.
Scandinavian Journal of Immunology (2020) Vol. 93, Iss. 2
Open Access | Times Cited: 129
Abdollah Jafarzadeh, Sara Jafarzadeh, Parvin Nozari, et al.
Scandinavian Journal of Immunology (2020) Vol. 93, Iss. 2
Open Access | Times Cited: 129
Immunological co-ordination between gut and lungs in SARS-CoV-2 infection
Shruti Ahlawat, Asha Asha, Krishna Kant Sharma
Virus Research (2020) Vol. 286, pp. 198103-198103
Open Access | Times Cited: 125
Shruti Ahlawat, Asha Asha, Krishna Kant Sharma
Virus Research (2020) Vol. 286, pp. 198103-198103
Open Access | Times Cited: 125
The role of IL-6 and IL-6 blockade in COVID-19
Nicola Potere, Alberto Batticciotto, Alessandra Vecchié, et al.
Expert Review of Clinical Immunology (2021) Vol. 17, Iss. 6, pp. 601-618
Closed Access | Times Cited: 102
Nicola Potere, Alberto Batticciotto, Alessandra Vecchié, et al.
Expert Review of Clinical Immunology (2021) Vol. 17, Iss. 6, pp. 601-618
Closed Access | Times Cited: 102
Is Toll-like receptor 4 involved in the severity of COVID-19 pathology in patients with cardiometabolic comorbidities?
Simone Cristina Soares Brandão, Júlia de Oliveira Xavier Ramos, Luca Terracini Dompieri, et al.
Cytokine & Growth Factor Reviews (2020) Vol. 58, pp. 102-110
Open Access | Times Cited: 89
Simone Cristina Soares Brandão, Júlia de Oliveira Xavier Ramos, Luca Terracini Dompieri, et al.
Cytokine & Growth Factor Reviews (2020) Vol. 58, pp. 102-110
Open Access | Times Cited: 89
Global BioID-based SARS-CoV-2 proteins proximal interactome unveils novel ties between viral polypeptides and host factors involved in multiple COVID19-associated mechanisms
Estelle Laurent, Yorgos Sofianatos, Anastassia V. Komarova, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 83
Estelle Laurent, Yorgos Sofianatos, Anastassia V. Komarova, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 83
Overview of COVID-19 inflammatory pathogenesis from the therapeutic perspective
Choong-Ho Lee, Won Jun Choi
Archives of Pharmacal Research (2021) Vol. 44, Iss. 1, pp. 99-116
Open Access | Times Cited: 83
Choong-Ho Lee, Won Jun Choi
Archives of Pharmacal Research (2021) Vol. 44, Iss. 1, pp. 99-116
Open Access | Times Cited: 83
Contribution of STAT3 to the pathogenesis of COVID-19
Abdollah Jafarzadeh, Maryam Nemati, Sara Jafarzadeh
Microbial Pathogenesis (2021) Vol. 154, pp. 104836-104836
Open Access | Times Cited: 83
Abdollah Jafarzadeh, Maryam Nemati, Sara Jafarzadeh
Microbial Pathogenesis (2021) Vol. 154, pp. 104836-104836
Open Access | Times Cited: 83
Circulating Calprotectin as a Biomarker of COVID-19 Severity
Michael Mähler, Pier Luigi Meroni, María Infantino, et al.
Expert Review of Clinical Immunology (2021) Vol. 17, Iss. 5, pp. 431-443
Open Access | Times Cited: 83
Michael Mähler, Pier Luigi Meroni, María Infantino, et al.
Expert Review of Clinical Immunology (2021) Vol. 17, Iss. 5, pp. 431-443
Open Access | Times Cited: 83
Smoking and Influenza-associated Morbidity and Mortality
Lefei Han, Jinjun Ran, Yim Wah Mak, et al.
Epidemiology (2019) Vol. 30, Iss. 3, pp. 405-417
Closed Access | Times Cited: 79
Lefei Han, Jinjun Ran, Yim Wah Mak, et al.
Epidemiology (2019) Vol. 30, Iss. 3, pp. 405-417
Closed Access | Times Cited: 79
SARS-CoV-2 suppresses mRNA expression of selenoproteins associated with ferroptosis, endoplasmic reticulum stress and DNA synthesis
Yijun Wang, Huang Jin, Yong Sun, et al.
Food and Chemical Toxicology (2021) Vol. 153, pp. 112286-112286
Open Access | Times Cited: 79
Yijun Wang, Huang Jin, Yong Sun, et al.
Food and Chemical Toxicology (2021) Vol. 153, pp. 112286-112286
Open Access | Times Cited: 79
Anti‐inflammatory and antiviral roles of hydrogen sulfide: Rationale for considering H2S donors in COVID‐19 therapy
Valentina Citi, Alma Martelli, Vincenzo Brancaleone, et al.
British Journal of Pharmacology (2020) Vol. 177, Iss. 21, pp. 4931-4941
Open Access | Times Cited: 78
Valentina Citi, Alma Martelli, Vincenzo Brancaleone, et al.
British Journal of Pharmacology (2020) Vol. 177, Iss. 21, pp. 4931-4941
Open Access | Times Cited: 78